What Are the Challenges in Targeting Pro Inflammatory Signals?
One of the main challenges is the dual role of inflammation in cancer. While chronic inflammation can promote cancer, acute inflammation is crucial for an effective immune response against tumors. Therefore, therapies targeting pro inflammatory signals must be carefully designed to avoid compromising the body's ability to fight cancer. Additionally, the tumor microenvironment is highly complex, and targeting a single pathway may not be sufficient to achieve a therapeutic effect.
